Lung cancer is the deadliest cancer in the United States, and 80% of lung cancer deaths are linked to one risk factor: smoking. While lung cancer screenings are a critical part of prevention and treatment for the disease and 15 million Americans qualify for yearly screenings, over half those eligible for screenings are still actively smoking. Without standard smoking cessation measures in place, the benefits of the screenings have not been fully realized.
screenings. Researchers from the School of Public Health, College of Liberal Arts, U.S. Department of Veterans Affairs and Allina Health also contributed to the study.
The Program for Lung Cancer Screening and Tobacco Cessation trial tested different adaptive interventions based on the evidence-based Tobacco Longitudinal Care program, in part to learn how best to incorporate TLC into annualas a smoking cessation standard. The trial assessed the effect of adding a referral to prescription medication therapy management to the TLC program among participants who did not respond to initial TLC treatment—i.e.
Among participants who did respond to initial TLC treatment, the quit rate for those receiving TLC quarterly was 44% compared to 59% for those receiving TLC monthly. The findings suggest that TLC was most effective when implemented without modification and does not need additional pharmacist resources. Integrating the TLC program—which consists of frequent telephone coaching and over-the-counter combination nicotine replacement therapy —with lung cancersmoking
, we will not adequately reap the benefits of lung cancer screening," said Steven Fu, a professor at the U of M Medical School, member of the Masonic Cancer Center and the lead author on the study."The PLUTO trial shows that we can deliver both intensive behavioral treatment and medications to help people quit by integrating a longitudinal tobacco cessation care program into the lung cancer screening setting.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Impacts on lung surgery of the removal of race-correction in lung pulmonary function testsRace-correction for spirometry, a type of pulmonary function test, is commonly done in medical institutions across the United States.
Read more »
Optimizing tissue oxygenation in breast reduction surgeryIn the last few years, breast reduction procedures in the U.S. have become increasingly common. According to the American Society of Plastic Surgeons, nearly 100,000 breast reduction procedures were performed in 2020.
Read more »
Researcher discusses how lung macrophages evolve during metastatic growth of lung colonies in a mouse model of melanomaA new editorial paper titled 'A macrophage is a macrophage is a macrophage—in metastasis' has been published in Oncotarget.
Read more »
Researchers discover novel approach for rebuilding, regenerating lung cellsResearchers from the Center for Regenerative Medicine (CReM), a joint venture between Boston University and Boston Medical Center, have discovered a novel approach for engrafting engineered cells into injured lung tissue. These findings may lead to new ways for treating lung diseases, such as emphysema, pulmonary fibrosis and COVID-19.
Read more »